NEOGENOMICS INC|4Aug 10, 6:19 PM ET

CARDOZA GEORGE 4

4 · NEOGENOMICS INC · Filed Aug 10, 2020

Form 4

Period: 2020-08-06

Chief Financial Officer

Transactions

Sale
Common Stock
2020-08-06$39.35/sh−82,500$3,246,375→ 350,902 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-08-06−100,000→ 0 total
Exercise: $7.15Exp: 2021-04-20→ Common Stock (100,000 underlying)
Exercise/Conversion
Common Stock
2020-08-06$7.15/sh+100,000$715,000→ 433,402 total

Holdings

Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (48,768 underlying)
48,768
Common Stock
(indirect: By Trust)
20,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (200,000 underlying)
200,000
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (51,459 underlying)
51,459
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (192,500 underlying)
192,500

Footnotes (5)

[F1]On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
[F2]On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
[F3]On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F4]On March 1, 2019, Mr. Cardoza was granted 51,459 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F5]On March 2, 2020, Mr. Cardoza was granted 48,768 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file